Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-20-034285

Options or other derivatives

  • Director acquired 6,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SCHEINBERG DAVID A Director 2020-03-12 Grant or award · Stock Option (Right to Buy) +6,500 6,500 D
Loading xslF345X03/tm2012902-2_form4.xml…